Orthofix medical.

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September 30, 2023. Net sales were $184.0 million, earnings per share (“EPS”) was $(0.77), and adjusted EPS was $0.07. “Orthofix has performed well and operated smoothly following the …Grant Applications. Orthofix’s mission is to improve patient’s lives by providing superior reconstruction and regenerative musculoskeletal solutions to physicians worldwide. In order to help fulfill this mission, when appropriate, Orthofix supports requests for grants and other charitable donations to be used in connection with medical ... Nov 22, 2023 · Orthofix Medical Stock Up 3.4 %. Shares of NASDAQ:OFIX opened at $11.19 on Tuesday. Orthofix Medical has a 1 year low of $9.57 and a 1 year high of $23.19. The company has a market cap of $411.31 million, a PE ratio of -2.87 and a beta of 1.05. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.58 and a quick ratio of 1.13. Conference Call. Orthofix will host a conference call today at 8:30 AM Eastern time to discuss the Company's financial results for the third quarter of 2022. Interested parties may access the conference call by dialing (888) 330-2508 in the U.S. and Canada, and (240) 789-2735 in all other locations, and referencing the access code 9556380.

28 Jul 2021 ... Orthofix Medical Inc. is a global medical device with a spine and orthopedics focus. Headquartered in Lewisville, Texas, Orthofix's spine ...

ORTHOFIX MEDICAL INC. Condensed Consolidated Balance Sheets (U.S. Dollars, in thousands, except par value data) December 31, 2022 December 31, 2021 Assets Current assets Cash and $ respectively 82,857 100,150 ...LEWISVILLE, Texas-- (BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, …

Thyroid hormones, including Synthroid and other thyroid medications, should never be used for the purpose of losing weight or treating obesity. Synthroid is a common type of thyroid hormone replacement. It is a manmade hormone used for the ...Medical equipment donations are a great way to help those in need. Whether you’re donating to a hospital, clinic, or other medical facility, there are a few things you should know before you donate. Here’s what you need to know about donati...Nov 8, 2023 · Orthofix Reports Third Quarter 2023 Results. November 8, 2023. Download. In November 2023, entered into a new four-year financing agreement with borrowing capacity of up to $150 million. Net sales of $184.0 million, an increase of 61% on a reported basis and an increase of 8% on a pro forma basis when normalizing for a one-time stocking order ... 10-Q. Effect of exchange rate changes on cash. Net change in cash and cash equivalents. Cash and cash equivalents at the end of period. Noncash investing activities - Purchase of intangible assets. The accompanying notes form an integral part of these condensed consolidated financial statements. ORTHOFIX MEDICAL INC.6 Mar 2023 ... Orthofix Medical Inc. - List of Subsidiaries. - EX-21 - March 06, 2023 ; Spinal Kinetics GmbH. Germany ; SeaSpine Holdings Corporation. US ; IsoTis ...

Sep 12, 2023 · Orthofix Announces Leadership Changes. September 12, 2023. Download. Catherine Burzik Appointed Interim Chief Executive Officer. Geoffrey Gillespie Appointed Interim Chief Financial Officer. Puja Leekha Appointed Interim Chief Legal Officer. LEWISVILLE, Texas-- (BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and ...

Introductory Note Effective at 12:01 a.m. Eastern Time on January 5, 2023, Orthofix Medical Inc., a Delaware corporation (“ Orthofix ”), completed the transactions contemplated by the definitive Agreement and Plan of Merger, dated as of October 10, 2022 (the “ Merger Agreement ”), by and among Orthofix, Orca Merger Sub Inc., a Delaware corporation …

Get the latest Orthofix Medical Inc (OFIX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Corporate Sustainability. Orthofix is committed to embedding sustainability throughout our business. We believe that all stakeholders must be considered in our actions every day. We approach issues surrounding sustainability with a mindset that is focused on providing superior solutions to physicians worldwide to improve the lives of patients.“The Board of Directors unanimously determined that Massimo is the right choice to lead Orthofix given his exceptional track record of delivering value creation …Orthofix Reports First Quarter 2023 Results. Net sales of $175.2 million, an increase of 65% on a reported basis and 12% on a pro forma constant currency basis over prior year. Bone Growth Therapies growth of 14%, with growth coming from both spine and fracture commercial channels. U.S. spinal implant sales up 18% over prior year on a pro forma ...Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company’s mission is to deliver innovative, quality-driven solutions while partnering with health ...Shares of Orthofix Medical ( OFIX 1.06%) were down more than 26% as of 2:15 p.m. ET on Tuesday after the healthcare company announced it had fired CEO Keith Valentine, CFO John Bostjancic, and ...Applicable risks and uncertainties include, among others: the ability of newly launched products to perform as designed and intended and to meet the needs of surgeons and patients, including as a result of the lack of robust clinical validation; and the risks identified under the heading “Risk Factors” in Orthofix Medical Inc.’s Annual ...

Orthofix Medical (NASDAQ: OFIX) is owned by 92.92% institutional shareholders, 13.59% Orthofix Medical insiders, and 0.00% retail investors. Cooper Robert Gaines is the largest individual Orthofix Medical shareholder, owning 1.53M shares representing 4.15% of the company.28 Jul 2021 ... Orthofix Medical Inc. is a global medical device with a spine and orthopedics focus. Headquartered in Lewisville, Texas, Orthofix's spine ...LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the U.S. Food and Drug Administration (FDA) pre-market approval for the AccelStim ™ bone healing therapy Class III device. The AccelStim device provides a safe and effective ...Orthofix Medical Inc. (NASDAQ:NASDAQ:OFIX) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ETCompany ParticipantsAlexa Huerta - Senior Director,...LEWISVILLE, Texas-- ( BUSINESS WIRE )-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the …Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and ...

Orthofix Medical Inc. ended the third quarter with just over $33 million in cash and marketable securities on its balance sheet. The company had also made use of $70 million of a five-year credit ...

Nov 28, 2023 · At Orthofix Medical Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. Nov 3, 2022 · Conference Call. Orthofix will host a conference call today at 8:30 AM Eastern time to discuss the Company's financial results for the third quarter of 2022. Interested parties may access the conference call by dialing (888) 330-2508 in the U.S. and Canada, and (240) 789-2735 in all other locations, and referencing the access code 9556380. Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers …Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full U.S. commercial launch of the WaveForm ® L Lateral Lumbar Interbody System. Designed for lateral ...• Orthofix Medical, Inc. Unique Offerings • Exhaustive coverage • Highest number of market tables and figures • Subscription based model available • Guaranteed best price • Assured ...LEWISVILLE, Texas, November 08, 2023--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September 30, 2023. Net sales were $184.0 million, earnings per ...

Jan 4, 2023 · Orthofix and SeaSpine Stockholders Approve Merger. LEWISVILLE, Texas, January 04, 2023--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the ...

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company’s mission is to deliver innovative, quality-driven solutions while partnering with health care professionals to improve patient mobility.

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that more than 60,000 M6-C artificial ...For the past 40 years, Orthofix Medical Inc. has been dedicated to improving patients’ lives by providing superior solutions to physicians worldwide. Today, …“The Board of Directors unanimously determined that Massimo is the right choice to lead Orthofix given his exceptional track record of delivering value creation and his extensive knowledge of the medical device industry, specifically within orthopedics and spine,” said Catherine Burzik, Chair of the Board of Directors and Interim CEO of Orthofix.Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today that Massimo Calafiore has been named incoming President and Chief Executive Officer. Mr ...Medical assistants are an integral part of the healthcare industry, providing support to doctors and other medical professionals in a variety of ways. As such, they are in high demand and can command a good salary depending on their experie...Orthofix Medical Inc. has had a lackluster performance in 2023 and has brought in a new CEO to turn the company around. The company's orthopedics business …Orthofix Medical Inc (Orthofix), formerly Orthofix International NV, is a medical device company that provides reconstruction and regenerative musculoskeletal solutions to physicians across the world. The company’s major products include motion preservation and fixation implant products, regenerative products and tissue forms, pediatrics and ... NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ: OFIX) concerning possible ...Orthofix Medical Inc. investors suffered their worst day in nearly 30 years on Tuesday, after the spine and orthopedics company fired three top executives “for cause.”. The company OFIX, +0.41 ...

Earnings for Orthofix Medical are expected to grow in the coming year, from ($3.16) to ($1.40) per share. Orthofix Medical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 4th, 2024 based off prior year's report dates. Read More.Orthofix Medical Inc. Jul 2020 - Dec 2022 2 years 6 months. Texas, United States Chief Legal and Administrative Officer Orthofix International, NV ...Orthofix Medical Inc. Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results. Download. January 4, 2023.LEWISVILLE, Texas--(BUSINESS WIRE)--Jul. 20, 2020-- Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products, today announced it has received the U.S. Food and Drug Administration (FDA) 510(k) clearance and European CE Mark approval for the JuniOrtho ® Plating …Instagram:https://instagram. water main insurance nycjenny harrington stock picksbest stock under dollar5fed decision on rates Orthofix Medical Inc. (NASDAQ:OFIX) Q3 2023 Earnings Call Transcript November 8, 2023 Orthofix Medical Inc. misses on earnings expectations. Reported EPS is $-0.77471 EPS, expectations were $-0.22. Operator: Hello. Good afternoon, and welcome to the Orthofix Third Quarter Earnings Conference Call. At this time, all participants are in a … tangem hardware wallethow to make money trading options Good afternoon, and welcome to Orthofix Medical's Q4 and Full Year 2022 Earnings Call. (Operator Instructions) As a reminder, this conference call is being recorded.Shares of Orthofix Medical (. OFIX Quick Quote. OFIX - Free Report) have plunged 4.5% since the release of its third-quarter earnings on Nov 8. The company delivered third-quarter 2023 adjusted ... trpkx NEW YORK, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc.: Due to the forgoing, The Gross …May 4, 2022 · LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the U.S. Food and Drug Administration (FDA) pre-market approval for the AccelStim ™ bone healing therapy Class III device. The AccelStim device provides a safe and effective ...